JACC: Case Reports (Oct 2023)

Long-Term Outcome of the First Completely Leadless Cardiac Resynchronization Therapy in the United States

  • Donald Mehlhorn, DO,
  • Sankalp Patel, DO,
  • Dhiran Verghese, MD,
  • Hashem Azad, DO,
  • Dinesh Sharma, MD

Journal volume & issue
Vol. 24
p. 102020

Abstract

Read online

Completely leadless cardiac resynchronization therapy is feasible with the combination of Micra AV pacemaker (Medtronic Inc) and WiSE-CRT (EBR Inc) systems. Several reports have highlighted this combination in Europe. This case report presents a 1- year follow-up the first reported concomitant use of the leadless systems in the United States. (Level of Difficulty: Advanced.)

Keywords